CASI
Companies
NASDAQ
Casi Pharmaceuticals Inc.
Health Care
$1.36
-$1.47 (-51.94%)
Price Chart
Overview
About CASI
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
Market Cap
$46.5M
Volume
21.1K
Avg. Volume
13.2K
P/E Ratio
-0.94370884
Dividend Yield
0.00%
Employees
243.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.83
Moderate Correlation
Volatility
High (0.94)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, CASI shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025